RECOVERY FROM SEVERE PARAQUAT POISONINGGALLOWAY DB; PETRIE JC.1972; POSTGRAD. MED. J.; G.B.; DA. 1972; VOL. 48; NO 565; PP. 684-686; BIBL. 8 REF.Serial Issue

DRUG INTERACTIONS IN PATIENTS ON LONG-TERM ORAL ANTICOAGULANT AND ANTIHYPERTENSIVE ADRENERGIC NEURON-BLOCKING DRUGS = INTERACTIONS MEDICAMENTEUSES CHEZ DES MALADES TRAITES A LONG TERME PAR DES ANTICOAGULANTS ORAUX ET PAR DES BLOQUANTS ADRENERGIQUES ANTIHYPERTENSEURSSTARR KJ; PETRIE JC.1972; BRIT. MED. J.; G.B.; DA. 1972; NO 5833; PP. 133-135; BIBL. 12 REF.Serial Issue

EROSIVE GASTRITIS AND DUODENITIS DURING CONTINUOUS CIMETIDINE TREATMENT.WEBSTER J; PETRIE JC; MOWAT NAG et al.1978; BRIT. MED. J.; G.B.; DA. 1978; NO 6104; PP. 20-21; BIBL. 3 REF.Article

PRACTOLOL AND BENDROFLUAZIDE IN TREATMENT OF HYPERTENSION = LE PRACTOLOL ET LE BENDROFLUAZIDE DANS LE TRAITEMENT DE L'HYPERTENSIONGALLOWAY DB; BEATTIE AG; PETRIE JC et al.1974; BRIT. HEART J.; G.B.; DA. 1974; VOL. 36; NO 9; PP. 867-871; BIBL. 3REF.Article

ATENOBOL AND METOPROBOL IN MILD HYPERTENSIONJEFFERS TA; WEBSTER J; REID B et al.1978; BRIT. MED. J.; GBR; DA. 1978; NO 6147; BIBL. 4 REF.Article

ATENOLOL, METHYLDOPA, AND CHLORTHALIDONE IN MODERATE HYPERTENSION.WEBSTER J; JEFFERS TA; GALLOWAY DB et al.1977; BRIT. MED. J.; G.B.; DA. 1977; NO 6053; PP. 76-78; BIBL. 4 REF.Article

ATENOLOL AND BENDROFLUAZIDE IN HYPERTENSION.PETRIE JC; GALLOWAY DB; WEBSTER J et al.1975; BRIT. MED. J.; G.B.; DA. 1975; NO 5989; PP. 133-135; BIBL. 6 REF.Article

PREVENTION OF ADVERSE DRUG INTERACTIONS.HOWIE JGR; JEFFERS TA; MILLAR HR et al.1977; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1977; VOL. 4; NO 5; PP. 611-614; BIBL. 5 REF.Article

ATENOLOL ONCE-DAILY IN HYPERTENSION.JEFFERS TA; WEBSTER J; PETRIE JC et al.1977; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1977; VOL. 4; NO 5; PP. 523-527; BIBL. 9 REF.Article

IN VIVO CYTOGENETIC ACTIVITY OF SULPHONYLUREA DRUGS IN MANWATSON WAF; PETRIE JC; GALLOWAY DB et al.1976; MUTATION RES.; NETHERL.; DA. 1976; VOL. 38; NO 1; PP. 71-80; BIBL. 13 REF.Article

THE PROTEIN BINDING OF VINBLASTINE IN THE SERUM OF NORMAL SUBJECTS AND PATIENTS WITH HODGKIN'S DISEASESTEELE WH; KING DJ; BARBER HE et al.1983; EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY; ISSN 0031-6970; DEU; DA. 1983; VOL. 24; NO 5; PP. 683-687; BIBL. 23 REF.Article

PHARMACOKINETICS OF ATENOLOL AND PROPRANOLOL IN YOUNG AND ELDERLY SUBJETSBARBER HE; HAWKSWORTH GM; PETRIE JC et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 11; NO 1; PP. 118P-119P; BIBL. 6 REF.Article

ATENOLOL AND METOPROLOL ONCE DAILY IN HYPERTENSIONSCOTT AK; RIGBY JW; WEBSTER J et al.1982; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1982; VOL. 284; NO 6328; PP. 1514-1516; BIBL. 8 REF.Article

METHYLDOPA AND PROPRANOLOL OR PRACTOLOL IN MODERATE HYPERTENSIONPETRIE JC; GALLOWAY DB; JEFFERS TA et al.1976; BRIT. MED. J.; G.B.; DA. 1976; PP. 137-139; BIBL. 2 REF.Article

CIMETIDINE. A CLINICAL AND PHARMACOKINETIC STUDYWEBSTER J; BARBER HE; HAWKSWORTH GM et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 11; NO 4; PP. 333-338; BIBL. 14 REF.Article